Monthly Archives February 2019

Click here to read the DISPATCH notification from PHARMAC relating to the resupply and reinstating the STAT (all-at-once) dispensing rule for the above mentioned product. The supply issue was originally advised 24 November 2018 and subsequently the STAT Dispensing Rule was removed 1 February 2019. (ref Mind Time article 19 January 2019) STAT is reinstated effective 1 March 2019 ProPharma…

Click here to access the analysis relating to the above mentioned product. To change brands early could prove to be costly. ProPharma / PWR in association with AFT have reduced the price to pharmacy of Fenpaed effective immediately, (from $2.63 to $2.37 excluding GST) offering you a significant opportunity to increase your $ margin on this product. On a high…

Click here to access the latest GSK deal which commences 1 March 2019 through until 31 March 2019. This order form is being made available early so that you can plan to take full advantage of this offer, however we are not able to process any orders faxed before 1 March 2019. Further for efficiency we would ask you all…

It was noted in the March Pharmaceutical Schedule Update that Mylan, the supplier of doxepin hydrochloride capsules, had notified PHARMAC that ANTEN CAPSULES have been discontinued internationally by their manufacturer. Stock remains available at present so there is no immediate cause for concern. However you will need to discuss with patients as we move closer to stock being depleted and…

If you have any medical or stock availability enquiries regarding the above products or require further information on anything in this communication,Please do not hesitate to contact Pfizer New Zealand Limited on 0800 736 363

As advised via Pharmac Tender announcement 31 August 2018 there is to be a change in the listing and future sole supply. New listing from 1 March 2019 Nivestim Inj 300 mcg per 0.5 ml prefilled syringe 10          Pharmacode 2561956  Schedule price $96.22 Nivestim Inj 480 mcg per 0.5 ml prefilled syringe 10          Pharmacode 2561964  Schedule price $161.50 Incumbent brand…

Click here to read the notification from Apotex relating to the resupply of the above mentioned product. During the period affected by the supply issue Apotex were able to supply AU stock as follows:- Clarithromycin-Apo Tab 250 mg 14     Pharmacode  2557231 As per Apotex notification - ProPharma / PWR will continue to supply the AU product until stocks are…

This is an update to our article of 14 February 2019. Effective from 1 March 2019 PHARMAC will list Flucon in the Pharmaceutical Schedule Fully Funded. Providing supplies of the new temporary listing are readily available then the FML allocation may be removed. Please note ProPharma / PWR will sell through existing supplies of FML prior to releasing stock of…

As advised via Pharmac Tender announcement 31 August 2018 there is to be a change in the listing and future sole supply. New listing from 1 February 2019 Aurorix Tab 150 mg 60                                        Pharmacode 2560429                  Schedule price $6.40 Aurorix Tab 300 mg 60                                        Pharmacode 2560437                              Schedule price $9.80 Incumbent brand Moclobemide-Apo Tab 150 mg 500                …

As advised via Pharmac Tender announcement 31 August 2018 there is to be a change in the listing and future sole supply. New listing from 1 March 2019 Foban Cream 2% 5 gm OP                                  Pharmacode 2556170                              Schedule price $1.59 Foban Ointment 2% 5 gm OP                             Pharmacode 2556189                              Schedule price $1.59 Incumbent brand Fusidic Acid DP Cream…

Close